SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-11-031082
Filing Date
2011-05-25
Accepted
2011-05-25 20:20:53
Documents
2
Period of Report
2011-05-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3873
2 POA DOCUMENT poa.txt EX-24.4_379897 3508
  Complete submission text file 0001209191-11-031082.txt   8856
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Issuer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address C/O PDL BIOPHARMA 932 SOUTHWOOD BOULEVARD INCLINE VILLAGE NV 89451
Business Address
LARSON CHRISTINE R (Reporting) CIK: 0001270013 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19756 | Film No.: 11872353